{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:54:11Z","timestamp":1774896851822,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10384-019-00674-7","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T10:02:56Z","timestamp":1560160976000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis)"],"prefix":"10.1007","volume":"63","author":[{"given":"Atsushi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meri","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"key":"674_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","volume":"50","author":"N Okhravi","year":"2005","unstructured":"Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol. 2005;50:351\u201363.","journal-title":"Surv Ophthalmol"},{"key":"674_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163\u201391.","journal-title":"Br J Ophthalmol"},{"key":"674_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","volume":"111","author":"EK Akpek","year":"2004","unstructured":"Akpek EK, Throne EJ, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501\u20136.","journal-title":"Ophthalmology"},{"key":"674_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/bjo.60.3.192","volume":"60","author":"DD McGavin","year":"1976","unstructured":"McGavin DD, Williamson J, Forrester JV, Foulds WS, Buchanan WW, Dick WC, et al. Episcleritis and scleritis. A study of their clinical manifestation and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60:192\u2013226.","journal-title":"Br J Ophthalmol"},{"key":"674_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1253\/circj.CJ-88-0007","volume":"75","author":"JCS Joint Working Group","year":"2011","unstructured":"JCS Joint Working Group. Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society. Circ J. 2011;75:474\u2013503.","journal-title":"Circ J"},{"key":"674_CR6","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A, Khouatra C, Auma\u00eetre O, Cohen P, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371:1771\u201380.","journal-title":"N Engl J Med"},{"key":"674_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363:221\u201332.","journal-title":"N Engl J Med"},{"key":"674_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10384-018-0600-y","volume":"62","author":"R Tanaka","year":"2018","unstructured":"Tanaka R, Kaburaki T, Ohtomo K, Takamoto M, Komae K, Numaga J, et al. Clinical characteristics and ocular complications of patients with scleritis in Japanese. Jpn J Ophthalmol. 2018;62:517\u201324.","journal-title":"Jpn J Ophthalmol"},{"key":"674_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","volume":"56","author":"N Ohguro","year":"2012","unstructured":"Ohguro N, Sonoda K, Takeuchi M, Matsumura M, Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56:432\u20135.","journal-title":"Jpn J Ophthalmol"},{"key":"674_CR10","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/bjo.2009.171744","volume":"94","author":"H Keino","year":"2010","unstructured":"Keino H, Watanabe T, Taki W, Nakashima C, Okada AA. Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol. 2010;94:1459\u201363.","journal-title":"Br J Ophthalmol"},{"key":"674_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5301\/ejo.5000394","volume":"24","author":"L Berichicci","year":"2014","unstructured":"Berichicci L, Miserocchi E, Di Nicola M, La Spina C, Bandello F, Modorati G. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center. Eur J Ophthalmol. 2014;24:293\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"674_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3109\/09273948.2013.840385","volume":"22","author":"LA Gonzalez-Gonzalez","year":"2014","unstructured":"Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, de la Maza SM, Foster CS. Clinical features and presentation of posterior scleritis: a report of 31 cases. Ocul Immunol Inflamm. 2014;22:203\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"674_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10384-008-0599-6","volume":"53","author":"S Oono","year":"2009","unstructured":"Oono S, Kurimoto T, Oku H, Mimura O. Adult T-cell leukemia presenting with episcleritis and secondary glaucoma. Jpn J Ophthalmol. 2009;53:70\u20131.","journal-title":"Jpn J Ophthalmol"},{"key":"674_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/bjo.2007.116830","volume":"91","author":"LK Smith","year":"2007","unstructured":"Smith LK, Suhler EB, Lim LL, Choi D, Cioffi GA, Rosenbaum JT. Possible association between scleritis and lymphoma. Br J Ophthalmol. 2007;91:1728\u20139.","journal-title":"Br J Ophthalmol"},{"key":"674_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archopht.126.5.651","volume":"126","author":"LT Hoang","year":"2008","unstructured":"Hoang LT, Lim LL, Vaillant B, Choi D, Rosenbaum JT. Antineutrophil cytoplamic antibody-associated active scleritis. Arch Ophthalmol. 2008;126:651\u20135.","journal-title":"Arch Ophthalmol"},{"key":"674_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","volume":"145","author":"P Lin","year":"2008","unstructured":"Lin P, Bhullar SS, Tessler HH, Goldstein DA. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol. 2008;145:463\u201371.","journal-title":"Am J Ophthalmol"},{"key":"674_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10384-011-0066-7","volume":"55","author":"K Kuroyanagi","year":"2011","unstructured":"Kuroyanagi K, Sakai T, Yoshida K, Yamada A, Shiba T, Tsuneoka H. Necrotizing scleritis in a patient positive for both c- and p-ANCA without underlying systemic vasculitis. Jpn J Ophthalmol. 2011;55:581\u20132.","journal-title":"Jpn J Ophthalmol"},{"key":"674_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12177-009-9044-4","volume":"3","author":"AS Watkins","year":"2010","unstructured":"Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, et al. Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Inform. 2010;3:12\u20139.","journal-title":"J Ocul Biol Dis Inform"},{"key":"674_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","volume":"102","author":"SM de la Maza","year":"1995","unstructured":"de la Maza SM, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687\u201392.","journal-title":"Ophthalmology"},{"key":"674_CR20","doi-asserted-by":"crossref","first-page":"bcr2013009583","DOI":"10.1136\/bcr-2013-009583","volume":"10","author":"S Alrashidi","year":"2013","unstructured":"Alrashidi S, Yousef YA, Krema H. Visaul loss from scleritis in C-ANCA microscopic polyangiitis. BMJ Case Rep. 2013;10:bcr2013009583.","journal-title":"BMJ Case Rep"},{"key":"674_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","volume":"119","author":"SM de la Maza","year":"2012","unstructured":"de la Maza SM, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis therapy. Ophthalmology. 2012;119:51\u20138.","journal-title":"Ophthalmology"},{"key":"674_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0161-6420(94)31325-X","volume":"101","author":"SM de la Maza","year":"1994","unstructured":"de la Maza SM, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389\u201396.","journal-title":"Ophthalmology"},{"key":"674_CR23","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","volume":"121","author":"EB Suhler","year":"2014","unstructured":"Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, et al. Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial. Ophthalmology. 2014;121:1885\u201391.","journal-title":"Ophthalmology"},{"key":"674_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1442-9071.1991.tb00663.x","volume":"19","author":"P McCluskey","year":"1991","unstructured":"McCluskey P, Wakefield D. Prediction of response to treatment in patients with scleritis using a standardised scoring system. Aust N Z J Ophthalmol. 1991;19:211\u20135.","journal-title":"Aust N Z J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-019-00674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-019-00674-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-019-00674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T12:54:04Z","timestamp":1721393644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-019-00674-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1007\/s10384-019-00674-7","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"24 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A. Yoshida, None; M. Watanabe, None; A. Okubo, None; H. Kawashima, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}